UB Paderborn / Katalog / Suche / in CDI

Understanding phenomena: From social to collective?

Philosophical issues, 2022-10, Vol.32 (1), p.253-267

Malfatti, Federica I.

2022

Volltextzugriff (PDF)

How science tracks understanding

Zagadnienia Filozoficzne w Nauce, 2024-03, Vol.74 (74), p.317-320

Malfatti, Federica

2024

Volltextzugriff (PDF)

Verstehen verstehen: Eine erkenntnistheoretische Untersuchung

Malfatti, Federica Isabella

2022

Volltextzugriff (PDF)

On Understanding and Testimony

Erkenntnis, 2021-12, Vol.86 (6), p.1345-1365

Malfatti, Federica Isabella

2021

Volltextzugriff (PDF)

Do We Deserve Credit for Everything We Understand?

Episteme, 2024-03, Vol.21 (1), p.187-206

Malfatti, Federica Isabella

2024

Volltextzugriff (PDF)

Introduction to the topical collection “True enough? Themes from Elgin”

Synthese (Dordrecht), 2021-12, Vol.199 (1-2), p.1293-1305

Malfatti, Federica Isabella

2021

Volltextzugriff (PDF)

Can Testimony Generate Understanding?

Social epistemology, 2019-11, Vol.33 (6), p.477-490

Malfatti, Federica Isabella

2019

Volltextzugriff (PDF)

Can Testimony Transmit Understanding?

Theoria (Lund, Sweden), 2020-02, Vol.86 (1), p.54-72

Malfatti, Federica I.

2020

Volltextzugriff (PDF)

HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients

Gastroenterology research and practice, 2015-01, Vol.2015, p.975695-7

2015

Volltextzugriff (PDF)

Towards Ideal Understanding

Ergo (Ann Arbor, Mich.), 2023-11, Vol.10

2023

Volltextzugriff (PDF)

The social fabric of understanding: equilibrium, authority, and epistemic empathy

Synthese (Dordrecht), 2021-12, Vol.199 (1-2), p.1185-1205

2021

Volltextzugriff (PDF)

Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C?

World journal of gastroenterology : WJG, 2013-11, Vol.19 (41), p.6947-6956

2013

Volltextzugriff (PDF)

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

Journal of hepatology, 2009-12, Vol.51 (6), p.984-990

2009

Volltextzugriff (PDF)

Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia

Case reports in hepatology, 2011-01, Vol.2011, p.258791-3

2011

Volltextzugriff (PDF)

Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection

The American journal of gastroenterology, 2003-11, Vol.98 (11), p.2516-2520

2003

Volltextzugriff (PDF)

Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection

The American journal of gastroenterology, 2003-11, Vol.98 (11), p.2516-2520

2003

Volltextzugriff (PDF)

Therapy of chronic hepatitis C with PEG-IFN α-2b plus ribavirin in patients with genotype 2 or 3: 16 versus 24 weeks, clinical outcome and direct cost analyses

European journal of gastroenterology & hepatology, 2013-12, Vol.25 (12), p.1396-1401

2013

Volltextzugriff (PDF)

Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis

Journal of hepatology, 2002-11, Vol.37 (5), p.572-577

2002

Volltextzugriff (PDF)

The 1-year and 3-month prognostic utility of the AST ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis

The American journal of gastroenterology, 2002-11, Vol.97 (11), p.2855-2860

2002

Volltextzugriff (PDF)

C-galactose breath test and C-aminopyrine breath test for the study of liver function in chronic liver disease

Clinical gastroenterology and hepatology, 2005-03, Vol.3 (3), p.279-285

2005

Volltextzugriff (PDF)

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

Archives of internal medicine (1960), 2003-01, Vol.163 (2), p.218

2003

Volltextzugriff (PDF)

Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?

Liver international, 2004-10, Vol.24 (5), p.465-470

2004

Volltextzugriff (PDF)

Influence of 1-Week Helicobacter pylori Eradication Therapy with Rabeprazole, Clarithromycin, and Metronidazole on super(13)C-Aminopyrine Breath Test

Digestive diseases and sciences, 2005-07, Vol.50 (7), p.1207-1213

2005

Volltextzugriff (PDF)

Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients

Digestive diseases and sciences, 2003-04, Vol.48 (4), p.802-808

2003

Volltextzugriff (PDF)

High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: Relationship with TNF-α levels

Digestive diseases and sciences, 2004-02, Vol.49 (2), p.275-280

2004

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Understanding phenomena: From social to collective?

How science tracks understanding

Verstehen verstehen: Eine erkenntnistheoretische Untersuchung

On Understanding and Testimony

Do We Deserve Credit for Everything We Understand?

Introduction to the topical collection “True enough? Themes from Elgin”

Can Testimony Generate Understanding?

Can Testimony Transmit Understanding?

HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients

Towards Ideal Understanding

The social fabric of understanding: equilibrium, authority, and epistemic empathy

Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C?

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia

Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection

Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection

Therapy of chronic hepatitis C with PEG-IFN α-2b plus ribavirin in patients with genotype 2 or 3: 16 versus 24 weeks, clinical outcome and direct cost analyses

Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis

The 1-year and 3-month prognostic utility of the AST ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis

C-galactose breath test and C-aminopyrine breath test for the study of liver function in chronic liver disease

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?

Influence of 1-Week Helicobacter pylori Eradication Therapy with Rabeprazole, Clarithromycin, and Metronidazole on super(13)C-Aminopyrine Breath Test

Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients

High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: Relationship with TNF-α levels

Suchergebnisse filtern